Advisory Commission on Childhood Vaccines; Notice of Meeting, 9010 [E7-3559]
Download as PDF
<![CDATA[
9010
Federal Register / Vol. 72, No. 39 / Wednesday, February 28, 2007 / Notices
Number of
respondents
Regulation citation
60.11(a)(7) Requests by Researchers for Aggregated Data ......................
60.14(b) Practitioner Places a Report in Disputed Status ..........................
60.14(b) Practitioner Statement ...................................................................
60.14(b) Practitioner Requests for Secretarial Review ...............................
60.3 Entity Registration—Initial ...................................................................
60.3 Entity Registration—Update ................................................................
60.11(a) Authorized Agent Designation—Initial ..........................................
60.11(a) Authorized Agent-Update ..............................................................
60.12(c) Account Discrepancy Report .........................................................
60.12(c) Electronic Funds Transfer Authorization .......................................
60.3 Entity Reactivation ...............................................................................
100
666
2,563
117
500
643
500
86
300
363
100
Total ......................................................................................................
........................
Hours per
response
(minutes)
Frequency of
responses
1
1
1
1
1
1
1
1
1
1
1
..........................
Total burden
hours
30
5
45
480
60
5
15
5
15
15
60
50
55
1,922
936
500
54
125
7
75
91
100
........................
293,644
Numbers in the table may not add up exactly due to rounding.
Send comments to Susan Queen, PhD,
HRSA Reports Clearance Officer, Room
10–33, Parklawn Building, 5600 Fishers
Lane, Rockville, Maryland 20857.
Written comments should be received
within 60 days of this notice.
Dated: February 22, 2007.
Alexandra Huttinger,
Acting Director, Division of Policy Review
and Coordination.
[FR Doc. E7–3446 Filed 2–27–07; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Commission on Childhood
Vaccines; Notice of Meeting
sroberts on PROD1PC70 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Advisory Commission on
Childhood Vaccines (ACCV).
Date and Time: March 7, 2007, 1 p.m.–5
p.m., EST. March 8, 2007, 9 a.m.–3:30 p.m.,
EST.
Place: Audio Conference Call and
Parklawn Building, Conference Rooms G & H,
5600 Fishers Lane, Rockville, MD 20857.
The ACCV will meet on Wednesday,
March 7, from 1 p.m. to 5 p.m., and on
Thursday, March 8, from 9 a.m. to 3:30 p.m.
The public can join the meeting in person at
the address listed above or by audio
conference call by dialing 1–888–947–9967
on March 7 and 8 and providing the
following information:
Leader’s Name: Dr. Geoffrey Evans.
Password: ACCV.
Agenda: The agenda items for the March
meeting will include, but are not limited to:
A discussion of VICP outreach activities; an
overview of the Vaccine Adverse Event
Reporting System, including the
requirements for the reporting of adverse
events; a report from the ACCV Futures
Workgroup; and updates from the Division of
VerDate Aug<31>2005
17:43 Feb 27, 2007
Jkt 211001
Vaccine Injury Compensation (DVIC),
Department of Justice, National Vaccine
Program Office, Immunization Safety Office
(Centers for Disease Control and Prevention),
National Institute of Allergy and Infectious
Diseases (National Institutes of Health), and
Center for Biologics and Evaluation Research
(Food and Drug Administration). Agenda
items are subject to change as priorities
dictate.
Public Comments: Persons interested in
providing an oral presentation should submit
a written request, along with a copy of their
presentation, to: Ms. Cheryl Lee, Principal
Staff Liaison, DVIC, Healthcare Systems
Bureau (HSB), Health Resources and Services
Administration (HRSA), Room 11C–26, 5600
Fishers Lane, Rockville, MD 20857 or e-mail:
clee@hrsa.gov. Requests should contain the
name, address, telephone number, and any
business or professional affiliation of the
person desiring to make an oral presentation.
Groups having similar interests are requested
to combine their comments and present them
through a single representative. The
allocation of time may be adjusted to
accommodate the level of expressed interest.
DVIC will notify each presenter by mail or
telephone of their assigned presentation time.
Persons who do not file an advance request
for a presentation, but desire to make an oral
statement, may announce it at the time of the
comment period. These persons will be
allocated time as it permits.
For Further Information Contact: Anyone
requiring information regarding the ACCV
should contact Ms. Cheryl Lee, Principal
Staff Liaison, DVIC, HSB, HRSA, Room 11C–
26, 5600 Fishers Lane, Rockville, MD 20857;
telephone (301) 443–2124 or e-mail:
clee@hrsa.gov.
Notification: Due to inclement weather, the
requirement that the public be notified of this
meeting at least 15 calendar days in advance
was not met.
Dated: February 22, 2007.
Alexandra Huttinger,
Acting Director, Division of Policy Review
and Coordination.
[FR Doc. E7–3559 Filed 2–27–07; 8:45 am]
BILLING CODE 4165–15–P
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review;
Comment Request; Request for
Genetic Studies in a Cohort of U.S.
Radiologic Technologists
SUMMARY: Under the provisions of
section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Cancer Institute, the National Institutes
of Health (NIH) has submitted to the
Office of Management and Budget
(OMB) a request to review and approve
the information collection listed below.
This proposed information collection
was previously published in the Federal
Register on December 29, 2006, pages
78445–78446 and allowed 60 days for
public comment. No public comments
were received. The purpose of this
notice is to allow an additional 30 days
for public comment. The National
Institutes of Health may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
Proposed Collection
Title: Genetic Studies in a Cohort of
U.S. Radiologic Technologists (formerly
known as ‘‘Generic Clearance to Collect
Medical Outcome and Risk Factor Data
from a Cohort of U.S. Radiologic
Technologists’’). Type of Information
Collection Request: Renewal with
change of a previously approved
collection (OMB No. 0925–0405,
expiration 02/28/2007). Need and Use
of Information Collection: The primary
aim of this collection is to substantially
increase knowledge about the possible
modifying role of genetic variation on
the long-term health effects associated
with protracted low-to moderate-dose
E:\FR\FM\28FEN1.SGM
28FEN1
]]>Agencies
[Federal Register Volume 72, Number 39 (Wednesday, February 28, 2007)]
[Notices]
[Page 9010]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-3559]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Commission on Childhood Vaccines; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), notice is hereby given of the following
meeting:
Name: Advisory Commission on Childhood Vaccines (ACCV).
Date and Time: March 7, 2007, 1 p.m.-5 p.m., EST. March 8, 2007,
9 a.m.-3:30 p.m., EST.
Place: Audio Conference Call and Parklawn Building, Conference
Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857.
The ACCV will meet on Wednesday, March 7, from 1 p.m. to 5 p.m.,
and on Thursday, March 8, from 9 a.m. to 3:30 p.m. The public can
join the meeting in person at the address listed above or by audio
conference call by dialing 1-888-947-9967 on March 7 and 8 and
providing the following information:
Leader's Name: Dr. Geoffrey Evans.
Password: ACCV.
Agenda: The agenda items for the March meeting will include, but
are not limited to: A discussion of VICP outreach activities; an
overview of the Vaccine Adverse Event Reporting System, including
the requirements for the reporting of adverse events; a report from
the ACCV Futures Workgroup; and updates from the Division of Vaccine
Injury Compensation (DVIC), Department of Justice, National Vaccine
Program Office, Immunization Safety Office (Centers for Disease
Control and Prevention), National Institute of Allergy and
Infectious Diseases (National Institutes of Health), and Center for
Biologics and Evaluation Research (Food and Drug Administration).
Agenda items are subject to change as priorities dictate.
Public Comments: Persons interested in providing an oral
presentation should submit a written request, along with a copy of
their presentation, to: Ms. Cheryl Lee, Principal Staff Liaison,
DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services
Administration (HRSA), Room 11C-26, 5600 Fishers Lane, Rockville, MD
20857 or e-mail: clee@hrsa.gov. Requests should contain the name,
address, telephone number, and any business or professional
affiliation of the person desiring to make an oral presentation.
Groups having similar interests are requested to combine their
comments and present them through a single representative. The
allocation of time may be adjusted to accommodate the level of
expressed interest. DVIC will notify each presenter by mail or
telephone of their assigned presentation time. Persons who do not
file an advance request for a presentation, but desire to make an
oral statement, may announce it at the time of the comment period.
These persons will be allocated time as it permits.
For Further Information Contact: Anyone requiring information
regarding the ACCV should contact Ms. Cheryl Lee, Principal Staff
Liaison, DVIC, HSB, HRSA, Room 11C-26, 5600 Fishers Lane, Rockville,
MD 20857; telephone (301) 443-2124 or e-mail: clee@hrsa.gov.
Notification: Due to inclement weather, the requirement that the
public be notified of this meeting at least 15 calendar days in
advance was not met.
Dated: February 22, 2007.
Alexandra Huttinger,
Acting Director, Division of Policy Review and Coordination.
[FR Doc. E7-3559 Filed 2-27-07; 8:45 am]
BILLING CODE 4165-15-P
